{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T16:37:44Z","timestamp":1782837464398,"version":"3.54.5"},"reference-count":31,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"accepted":{"date-parts":[[2022,11,6]]},"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:p>Congenital human cytomegalovirus (CMV) infection is the most common congenital infection, affecting around 1 in 200 infants in high-income settings. It can have life-long consequences for up to one in four children, including sensorineural hearing loss and neurodisability. Despite the frequency of congenital CMV and the severity for some children, it is a little-known condition by pregnant women, families and healthcare providers. Timely diagnosis of CMV infection in pregnancy is important to facilitate consideration of treatment with valaciclovir, which may reduce the risk of transmission to the fetus or reduce the severity of the outcomes for infected infants. Recognition of features of congenital CMV is important for neonatologists, paediatricians and audiologists to prompt testing for congenital CMV within the first 21 days of life. Early diagnosis gives the opportunity for valganciclovir treatment, where appropriate, to improve outcomes for affected infants. Further research is urgently needed to inform decisions about antenatal and neonatal screening, long-term outcomes for asymptomatic and symptomatic infants, predictors of these outcomes and optimal treatment for women and infants.<\/jats:p>","DOI":"10.1136\/archdischild-2022-323809","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T18:20:41Z","timestamp":1669659641000},"page":"601-607","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":34,"title":["Managing challenges in congenital CMV: current thinking"],"prefix":"10.1136","volume":"108","clinical-trial-number":[{"clinical-trial-number":"nct03301415","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01649869","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02005822","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1523-2368","authenticated-orcid":false,"given":"Christine E","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3266-1041","authenticated-orcid":false,"given":"Heather","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4764-229X","authenticated-orcid":false,"given":"Alasdair","family":"Bamford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1922-6208","authenticated-orcid":false,"given":"Anna","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B","family":"Dorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6350-6557","authenticated-orcid":false,"given":"Simon B","family":"Drysdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2802-7670","authenticated-orcid":false,"given":"Asma","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7540-7433","authenticated-orcid":false,"given":"Paul T","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermione","family":"Lyall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6070-9850","authenticated-orcid":false,"given":"Kate Monica Isabel","family":"Ralph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7648-4601","authenticated-orcid":false,"given":"Shari","family":"Sapuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1140-8445","authenticated-orcid":false,"given":"Tushna","family":"Vandrevala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7944-8793","authenticated-orcid":false,"given":"Elizabeth","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"2025050107501161000_108.8.601.1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.20736","article-title":"Congenital cytomegalovirus infection burden and epidemiologic risk factors in countries with universal screening: a systematic review and meta-analysis","volume":"4","author":"Ssentongo","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025050107501161000_108.8.601.2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/dmcn.13556","article-title":"Long-Term impairment attributable to congenital cytomegalovirus infection: a retrospective cohort study","volume":"59","author":"Korndewal","year":"2017","journal-title":"Dev Med Child Neurol"},{"key":"2025050107501161000_108.8.601.3","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2022-324007"},{"key":"2025050107501161000_108.8.601.4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2020-000844","article-title":"Parenting a child with congenital cytomegalovirus infection: a qualitative study","volume":"4","author":"Vandrevala","year":"2020","journal-title":"BMJ Paediatr Open"},{"key":"2025050107501161000_108.8.601.5","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2018-316010"},{"key":"2025050107501161000_108.8.601.6","doi-asserted-by":"crossref","DOI":"10.1016\/j.midw.2022.103249","article-title":"Experiences of pregnant women and healthcare professionals of participating in a digital antenatal CMV education intervention","volume":"106","author":"Montague","year":"2022","journal-title":"Midwifery"},{"key":"2025050107501161000_108.8.601.7","doi-asserted-by":"crossref","unstructured":"Vandrevala T , Barber V , Calvert A . Understanding pregnant women\u2019s readiness to engage in risk-reducing measures to prevent infections during pregnancy. J Health Psychol 2019;1359105319884609.","DOI":"10.1177\/1359105319884609"},{"key":"2025050107501161000_108.8.601.8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/INF.0000000000002763","article-title":"Prevention of acquisition of cytomegalovirus infection in pregnancy through Hygiene-based behavioral interventions: a systematic review and gap analysis","volume":"39","author":"Barber","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"2025050107501161000_108.8.601.9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ajog.2020.05.038","article-title":"Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences","volume":"223","author":"Chatzakis","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"2025050107501161000_108.8.601.10","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/uog.23685","article-title":"Secondary prevention of congenital cytomegalovirus infection with valacyclovir following maternal primary infection in early pregnancy","volume":"58","author":"Faure\u2010Bardon","year":"2021","journal-title":"Ultrasound in Obstet & Gyne"},{"key":"2025050107501161000_108.8.601.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31868-7"},{"key":"2025050107501161000_108.8.601.12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/uog.21991","article-title":"ISUOG practice guidelines: role of ultrasound in congenital infection","volume":"56","author":"Khalil","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2025050107501161000_108.8.601.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.04.003"},{"key":"2025050107501161000_108.8.601.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2015.09.019"},{"key":"2025050107501161000_108.8.601.15","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-305276"},{"key":"2025050107501161000_108.8.601.16","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1093\/cid\/cit609","article-title":"Congenital cytomegalovirus infection: audiologic outcome","volume":"57 Suppl 4","author":"Fowler","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2025050107501161000_108.8.601.17","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-3441"},{"key":"2025050107501161000_108.8.601.18","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2020.5441","article-title":"Sensitivity of dried blood spot testing for detection of congenital cytomegalovirus infection","volume":"175","author":"Dollard","year":"2021","journal-title":"JAMA Pediatr"},{"key":"2025050107501161000_108.8.601.19","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/INF.0000000000002808","article-title":"Prevalence and clinical manifestations of congenital cytomegalovirus infection in a screening program in Madrid (PICCSA study)","volume":"39","author":"Bl\u00e1zquez-Gamero","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"2025050107501161000_108.8.601.20","doi-asserted-by":"crossref","first-page":"942.e7","DOI":"10.1016\/j.crad.2021.09.015","article-title":"Diagnostic analysis of baseline brain MRI features in infants with congenital cytomegalovirus infection: a simplified scoring system","volume":"76","author":"Kachramanoglou","year":"2021","journal-title":"Clin Radiol"},{"key":"2025050107501161000_108.8.601.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(03)00192-6"},{"key":"2025050107501161000_108.8.601.22","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.jcv.2009.08.012","article-title":"Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system","volume":"46 Suppl 4","author":"Oliver","year":"2009","journal-title":"J Clin Virol"},{"key":"2025050107501161000_108.8.601.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1404599"},{"key":"2025050107501161000_108.8.601.24","first-page":"1205","article-title":"Congenital cytomegalovirus","volume":"36","author":"Luck","year":"2017","journal-title":"PIDJ"},{"key":"2025050107501161000_108.8.601.25","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30143-3"},{"key":"2025050107501161000_108.8.601.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.02.028"},{"key":"2025050107501161000_108.8.601.27","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1938","article-title":"Hearing and neurodevelopmental outcomes for children with asymptomatic congenital cytomegalovirus infection: a systematic review","volume":"27","author":"Bartlett","year":"2017","journal-title":"Rev Med Virol"},{"key":"2025050107501161000_108.8.601.28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00431-019-03558-7","article-title":"Treatment of congenital cytomegalovirus beyond the neonatal period: an observational study","volume":"179","author":"Dorfman","year":"2020","journal-title":"Eur J Pediatr"},{"key":"2025050107501161000_108.8.601.29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jiac.2020.08.019","article-title":"Efficacy, safety, and pharmacokinetics of oral valganciclovir in patients with congenital cytomegalovirus infection","volume":"27","author":"Suganuma","year":"2021","journal-title":"J Infect Chemother"},{"key":"2025050107501161000_108.8.601.30","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.3390\/jcm11133582","article-title":"Oral valganciclovir therapy in infants aged \u22642 months with congenital cytomegalovirus disease: a multicenter, single-arm, open-label clinical trial in Japan","volume":"11","author":"Morioka","year":"2022","journal-title":"J Clin Med"},{"key":"2025050107501161000_108.8.601.31","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-010-1176-9"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2022-323809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T18:38:17Z","timestamp":1746643097000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2022-323809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,7,19]]},"published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1136\/archdischild-2022-323809"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2022-323809","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]}}}